Profile data is unavailable for this security.
About the company
Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Company’s Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.
- Revenue in USD (TTM)1.90bn
- Net income in USD-3.31m
- Incorporated1996
- Employees3.70k
- LocationNU Skin Enterprises IncATTN: D. MATTHEW DORNY75 WEST CENTER STPROVO 84601United StatesUSA
- Phone+1 (801) 345-6100
- Fax+1 (801) 345-5999
- Websitehttps://www.nuskin.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adcock Ingram Holdings Limited | 508.35m | 48.33m | 490.42m | 2.39k | 10.02 | 1.52 | -- | 0.9647 | 5.49 | 5.49 | 57.72 | 36.26 | 1.12 | 2.52 | 4.38 | -- | 10.68 | 10.50 | 14.81 | 14.90 | 34.32 | 32.38 | 9.51 | 9.34 | 0.9352 | -- | 0.0806 | 40.35 | 4.89 | 7.43 | 12.25 | 7.45 | -7.92 | 7.77 |
| Shanghai New World Co Ltd | 158.20m | 4.64m | 570.20m | 1.20k | 122.88 | 0.9818 | -- | 3.60 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| YSB Inc | 2.34bn | -440.49m | 645.45m | 6.31k | -- | 2.43 | -- | 0.2753 | -25.58 | -25.58 | 47.38 | 3.23 | -- | -- | -- | 2,901,239.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
| Nu Skin Enterprises, Inc. | 1.90bn | -3.31m | 666.04m | 3.70k | -- | 0.8226 | 9.64 | 0.3496 | -0.0758 | -0.0758 | 37.80 | 16.30 | 1.07 | 1.90 | 29.99 | 514,858.10 | -0.1858 | 6.80 | -0.2298 | 8.90 | 68.42 | 73.45 | -0.174 | 5.26 | 1.24 | 7.94 | 0.3736 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
| Uniphar PLC | 2.77bn | 48.64m | 770.49m | 3.26k | 15.84 | 2.13 | 8.81 | 0.278 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
| NanJing Pharmaceutical Co Ltd | 7.39bn | 81.20m | 885.21m | 4.90k | 10.84 | 0.9614 | -- | 0.1199 | 0.4513 | 0.4513 | 41.07 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 7.48m | 15.13% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 6.32m | 12.79% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 2.04m | 4.13% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 1.80m | 3.64% |
| Charles Schwab Investment Management, Inc.as of 31 Mar 2024 | 1.39m | 2.81% |
| Geode Capital Management LLCas of 31 Mar 2024 | 1.08m | 2.19% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 1.07m | 2.17% |
| D. E. Shaw & Co. LPas of 31 Mar 2024 | 980.89k | 1.99% |
| Aristotle Capital Boston LLCas of 31 Mar 2024 | 811.51k | 1.64% |
| Federated MDTA LLCas of 31 Mar 2024 | 624.82k | 1.26% |
